Literature DB >> 8260266

Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations?

A D Struthers.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8260266      PMCID： PMC1025346          DOI： 10.1136/hrt.70.5.397

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  14 in total

1.  The differential response in atrial natriuretic peptide release during exercise in patients with and without ischemic heart disease.

Authors:  D C Hu; E F Wong; N L Wong
Journal:  Am J Med Sci       Date:  1988-08       Impact factor: 2.378

2.  Correlates of plasma atrial natriuretic factor in health and hypertension.

Authors:  P Montorsi; G Tonolo; J Polonia; D Hepburn; A M Richards
Journal:  Hypertension       Date:  1987-12       Impact factor: 10.190

3.  A new natriuretic peptide in porcine brain.

Authors:  T Sudoh; K Kangawa; N Minamino; H Matsuo
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

4.  Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brain.

Authors:  T Sudoh; N Minamino; K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1988-09-15       Impact factor: 3.575

5.  Increased plasma levels of brain natriuretic peptide in hypertrophic cardiomyopathy.

Authors:  M Yoshibayashi; T Kamiya; Y Saito; H Matsuo
Journal:  N Engl J Med       Date:  1993-08-05       Impact factor: 91.245

6.  Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.

Authors:  J G Motwani; H McAlpine; N Kennedy; A D Struthers
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

7.  Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.

Authors:  A M Richards; I G Crozier; T G Yandle; E A Espiner; H Ikram; M G Nicholls
Journal:  Br Heart J       Date:  1993-05

8.  Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly.

Authors:  K M Davis; L C Fish; D Elahi; B A Clark; K L Minaker
Journal:  JAMA       Date:  1992-05-20       Impact factor: 56.272

9.  Clearance of brain natriuretic peptide in patients with chronic heart failure: indirect evidence for a neutral endopeptidase mechanism but against an atrial natriuretic peptide clearance receptor mechanism.

Authors:  C C Lang; J G Motwani; W J Coutie; A D Struthers
Journal:  Clin Sci (Lond)       Date:  1992-06       Impact factor: 6.124

10.  Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

Authors:  M Yoshimura; H Yasue; E Morita; N Sakaino; M Jougasaki; M Kurose; M Mukoyama; Y Saito; K Nakao; H Imura
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690
View more
  10 in total

Review 1.  Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.

Authors:  R S McKelvie; C R Benedict; S Yusuf
Journal:  BMJ       Date:  1999-05-22

2.  Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.

Authors:  A Clerico; G Iervasi; M G Del Chicca; M Emdin; S Maffei; M Nannipieri; L Sabatino; F Forini; C Manfredi; L Donato
Journal:  J Endocrinol Invest       Date:  1998-03       Impact factor: 4.256

Review 3.  Neuroendocrine changes in chronic cardiac failure.

Authors:  D P Nicholls; G N Onuoha; G McDowell; J S Elborn; M S Riley; A M Nugent; I C Steele; C Shaw; K D Buchanan
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

4.  Investigation in general practice of patients with suspected heart failure: how should the essential echocardiographic service be delivered?

Authors:  M C Colquhoun; C Waine; M J Monaghan; A D Struthers; P G Mills
Journal:  Br J Gen Pract       Date:  1995-10       Impact factor: 5.386

Review 5.  Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use?

Authors:  A D Struthers
Journal:  BMJ       Date:  1994-06-18

6.  Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only.

Authors:  Allan D Struthers
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

7.  Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice.

Authors:  D R Murdoch; J Byrne; J J Morton; T A McDonagh; S D Robb; S Clements; I Ford; J J McMurray; H J Dargie
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

8.  Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction.

Authors:  G Jakob; J Mair; M Pichler; B Puschendorf
Journal:  Br Heart J       Date:  1995-02

Review 9.  Management of patients after their first myocardial infarction.

Authors:  A D Flapan
Journal:  BMJ       Date:  1994-10-29

10.  Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.

Authors:  V V Bonarjee; T Omland; D W Nilsen; K Caidahl; J A Sundsfjord; K Dickstein
Journal:  Br Heart J       Date:  1995-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.